Studies have raise that mifepristo...

Studies have raise that mifepristone (Mifeprex), a progesterone antagonist, may attemper the cervix and cause uterine contractions. This medication has been shown to be effective for elective abortions and medical termination of pregnancy during the first trimester, leading to studies of the general intent of mifepristone in term pregnancies. be the effects of these studies have demonstrated that mifepristone may ripen the cervix and induce labor while not increasing the risk to the fetus. However, mostly of these studies were small, and the dosing schedules were varied. Berkane and colleagues evaluated the effectiveness of mifepristone in ripening the cervix and inducing labor in spell pregnancies.

The prospective double-blind, placebo-controlled thought included patients at multiple medical center The inclusion criteria were a singleton pregnancy between 37 and 41 weeks of gestation plus three days, a medical indication for delivery within 48 hours, and an unripe cervix (Bishop score of 4 or less) Patients were exclud if they had a contraindication to labor, were undergoing steroid therapy, had renal failure or diabetes, or underwent aspirin or nonsteroidal anti-inflammatory physic therapy within the previous 15 days. Participants were randomized to receive 50 100 200 400 or 600 mg of mifepristone or placebo. Maternal and umbilical arterial progeny samples were drawn for mifepristone assay. Umbilical vein cord progeny was assayed for adrenocorticotropin hormone and cortisol plains Effectiveness of mifepristone was defined as labor between 12 and 45/54 hours from the start of treatment. Labor was defined as uterine contractions that gradually changed the cervix or a Bishop score of 6 or higher. Those who reached a Bishop score of 6 without labor had an amniotomy and oxytocin infusion. Maternal and fetal tolerability of mifepristone were assessed.

The meditation included 346 patients. There were no significant differences between the treatment clusters in demographics or medical and obstetric history. The main indications for labor induction were post-term hypertension, fetal disease (eg small for gestational age or macrosomia), premature break of membranes, polyhydramnios, or oligohydramnios. The mifepristone treatment was lucky in 52.7 percent of patients with no significant difference across the labor induction form into groupss The rate of vaginal deliveries and fetal tolerability also were similar in all of the thought groups. Four serious maternal adverse marked occurrences occurred--three patients with uterine hypertony and the same with maternal bradycardia. No significant differences between the various disposes were found when the incidence of acute fetal distress was analyzed. Labor was extended in the groups that received 400 and 600 mg of mifepristone compared with those receiving lower dosages.

The authors deduce that up to 600 mg of mifepristone does not induce labor in patients with unfavorable cervical status. They add that the failure of mifepristone in this consideration may be secondary to the conditions in which it was used. Other studies are needinessed to determine whether mifepristone effectively induces labor.

KARL E MILLER, MD

Berkane N et al. Use of mifepristone to ripen the cervix and induce labor in expression pregnancies. Am J Obstet Gynecol January 2005;192:114-20

The trade names of physics listed in POEMs and Tips from Other Journals are the first version of the put drugs into that was released and not necessarily the brand of unsalable article that was used in the application of mind being discussed.

COPYRIGHT 2005 American Academy of Family Physicians

COPYRIGHT 2005 Gale Group